John Freshley Overview
- Firm
- John Freshley
- Primary Position
-
Angel Investor
- Primary Industry
-
Information Technology
- Med. Deal Size
-
- Med. Valuation
-
John Freshley General Information
Biography
Mr. John Freshley is an Angel Investor. Mr. Freshley served as Venture Partner at Orange Grove Bio. He serves as an Advisor at Cantilever Investors. Previously, Mr. Freshley served as the Chief Executive Officer, President and a Board Member at ONL Therapeutics. John has seventeen years in leadership roles of fast-paced entrepreneurial companies within both the software and life science fields. John has expertise in assembling multi-disciplinary leadership teams; product and business strategy development; partnership development and communications; and experience in venture capital fund-raising. Most recently, John was Chief Business Officer of Compendia Bioscience through its acquisition by Life Technologies. John helped start the company in 2006 with co-founders from the University of Michigan and served as its interim CEO, assembling the management team, securing initial funding and acquiring the company's first 10 customers. Previously, John had been President and CEO of Genetics Squared, an Ann Arbor start-up focused on developing personalized oncology drugs and diagnostics.
Contact Information
Address
- 600 South Wagner
- Ann Arbor, MI 48013
- United States
John Freshley Lead Partner on Deals (2)
John Freshley has been the lead partner on 2 deals. Their latest deal was with Larky, a business/productivity software company. The deal was made for on 12-Jul-2019.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Larky | 12-Jul-2019 | Later Stage VC (Series B) | Completed | Business/Productivity Software | Ann Arbor, MI | |
Avegant | 28-Aug-2018 | Completed | Other Hardware | San Mateo, CA |
John Freshley Network (43)
Board Members (19)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Christine Gibbons | ONL Therapeutics | Self | Ann Arbor, MI | |
Cynthia Grosskreutz MD | ONL Therapeutics | ONL Therapeutics | Ann Arbor, MI | |
ONL Therapeutics | Novartis Venture Fund | Ann Arbor, MI | ||
ONL Therapeutics | Bios Partners | Ann Arbor, MI | ||
ONL Therapeutics | Visionary Venture Fund | Ann Arbor, MI |
Portfolio Executives (24)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Steve Reich | Larky | Advisor | 12-Jul-2019 | Ann Arbor, MI |
John Nechiporchik | Larky | Vice President, Client Services | 12-Jul-2019 | Ann Arbor, MI |
Larky | Co-Founder, Chief Executive Officer, President & Board Member | 12-Jul-2019 | Ann Arbor, MI | |
Larky | Executive Officer, Co-Founder & Secretary | 12-Jul-2019 | Ann Arbor, MI | |
Larky | Chief Technology Officer | 12-Jul-2019 | Ann Arbor, MI |
John Freshley Advisory Roles (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
Cantilever Investors | Investor | Advisor | Ann Arbor, MI | Venture Capital |
John Freshley FAQs
-
Who is John Freshley?
Mr. John Freshley is an Angel Investor.
-
How much does John Freshley typically invest?
John Freshley's median deal size is
. -
What is John Freshley’s main position?
John Freshley’s primary position is Angel Investor.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »